Home > Offer to Sell > Pharmaceuticals and Biochemicals > Respiratory system agents > Goserelin acetate
Goserelin acetate
Inquiry
| Post Date: | Sep 21,2016 |
| Expiry Date: | Sep 21,2017 |
| Detailed Description: |
Cas No. :145781-92-6
Quantity: 1Kilograms Specs:alisa@pharm-china.com Price:1 USD Kilograms Payment Method: Western Union, MoneyGram, Bank transfer, Bite Goserelin acetate 1. Quick Details: Androgen deprivation therapy may prolong the QT/QTc interval. Providers should consider whether the benefits of androgen deprivation therapy outweigh the potential risks in patients with congenital long QT syndrome, congestive heart failure, frequent electrolyte abnormalities, and in patients taking drugs known to prolong the QT interval. Electrolyte abnormalities should be corrected. Consider periodic monitoring of electrocardiograms and electrolytes. 2. We Guarantee: a. Fast Delivery: 3 work days after received payment. b. Free Resending: For long term cooperation, we guarantee all our customers will get their stuffs. c. Long Term Cooperation Discount: 5% DISCOUNT for our regular customers. 3. Hot sell: Injection liquid Name Specification Deca 200 200mg/ml Deca 250 250mg/ml Anadrol 50 50mg/ml Anavar 50 50mg/ml Anomass 400 400mg/ml Boldenone Acetate 100 100mg/ml (Boldenone Cypionate) 200mg/ml (Boldenone undecylenate) 300mg/ml Clomid 50 50mg/ml Cypoject 250 (Testosterone Cypionate) 600mg/ml Dianabol 250 250mg/ml Durabolin 250 250mg/ml Enanject 250 (Testosterone Enanthate) 250mg/ml Enanject 600 (Testosterone Enanthate) 600mg/ml Femara 5 5mg/ml NPP 200 200mg/ml (Nandrolone Cypionate) 200mg/ml Nolvadex 20 20mg/ml Winstrol 50 50mg/ml Propionat 100 (Testosterone Propionate) 100mg/ml Propionat 200 (Testosterone Propionate) 200mg/ml Sustanon 200 200mg/ml Sustanon 250 250mg/ml Sustanon 300 300mg/ml Sustanon 400 400mg/ml Undecanoate 500 (Testosterone Undecanoate) 500mg/ml Trenabol 100 100mg/ml Trenabolic 80 (Trenbolone Acetate) 80mg/ml Trenabolic 100 (Trenbolone Acetate) 100mg/ml Trenabolic 200 (Trenbolone Acetate) 200mg/ml Trenaject 60 (Trenbolone enanthate) 60mg/ml Trenaject 100 (Trenbolone Enanthate) 100mg/ml Trenaject 150 (Trenbolone Enanthate) 150mg/ml Trenaject 200 (Trenbolone Enanthate) 200mg/ml Parabolone 50 (Tren hex) 50mg/ml Masteron 100 (Drostanolone Propionate) 100mg/ml Masteron 200 (Drostanolone Enanthate) 200mg/ml Primoject 100 (Methenolone Enanthate) 100mg/ml TMT Blend 375 (Trenbolone Enanthate 125mg/ml; Drostanolone Enanthate 125mg/ml;Testosterone Enanthate 125mg/ml) TM Blend 500(Trenbolone Enanthate 250mg/ml Drostanolone Enanthate 250mg/ml) Raw Powder 1 Testosterone enanthate CAS: 315-37-7 2 Testosterone acetate CAS: 1045-69-8 3 Testosterone propionate CAS: 57-85-2 5 Testosterone cypionate CAS: 58-20-8 6 Testosterone phenylpropionate CAS: 1255-49-8 7 Testosterone isocaproate CAS: 15262-86-9 8 Testosterone decanoate CAS: 5721-91-5 9 Testosterone Sustanon 250 10 Testosterone undecanoate CAS: 5949-44-0 11 Turinabol (4-Chlorotestosterone acetate) CAS: 855-19-6 12 Oral turinabol CAS: 2446-23-3 13 Stanolone (androstanolone) CAS: 521-18-6 14 Nandrolone Decanoate (DECA) CAS: 360-70-3 15 Nandrolone Cypionate CAS: 601-63-8 16 Nandrolone Phenypropionate (Durabolin) CAS: 62-90-8 17 Boldenone Undecylenate (Equipoise) CAS: 13103-34-9 18 Boldenone Acetate CAS :2363-59-9 19 Drostanolone Propionate (Masteron) CAS: 521-12-0 20 Drostanolone Enanthate CAS: 472-61-1 21 Superdrol Powder (methyl-drostanolone) CAS: 3381-88-2 22 Trenbolone Acetate (Finaplix H/Revalor-H) CAS: 10161-34-9 23 Trenbolone Enanthate (parabolan) CAS: 10161-33-8 24 Trenbolone Hexahydrobenzyl Carbonate CAS: 23454-33-3 25 Epiandrosterone CAS: 481-29-8 26 Dehydroisoandrosterone Acetate CAS: 853-23-6 27 CAS: 566-19-8 28 Methenolone Enanthate (Primobolan) CAS: 303-42-4 29 Methenolone Acetate CAS: 434-05-9 30 Methandrostenolone(Dianabol) CAS: 72-63-9 31 Tamoxifen Citrate (Nolvadex) CAS: 54965-24-1 32 Clomiphene citrate CAS: 50-41-9 33 Toremifene citrate CAS: 89778-27-8 34 Letrazole(Femara) CAS: 112809-51-5 35 vardenafil CAS: 831217-01-7 36 Dapoxetine CAS: 119356-77-3 37 Dapoxetine HCl CAS: 1071929-03-7 38 Dutasteride CAS: 164656-23-9 39 Finasteride CAS: 98319-26-7 40 Yohimbine HCl CAS: 65-19-0 MGF (2mg/vial) CJC-1295DAC 863288-34-0 (2mg/vial) PT-141 32780-32-8 (10mg/vial) Melanotan-II (10mg/vial) GHRP-6 87616-84-0 (5mg/vial) Hexarelin 140703-51-1 (2mg/vial) Oxytocin (2mg/vial) pentadecapeptide BPC 157 (2mg/vial) Triptorelin Acetate (2mg/vial) Tesamorelin 106612-94-6 (2mg/vial) Selank (5mg/vial) Carbetocin Acetate 37025-55-1 (1G / foil bag) EGF 62253-63-8 (1KG / fluorinated bottle) Thymosin α1 Acetate 62304-98-7 (1G / polypeptide tube) PEG-MGF (2mg/vial) CJC-1295 (2mg/vial) Melanotan-I (10mg/vial) GHRP-2 158861-67-7 (5mg/vial) Ipamorelin 170851-70-4 (2mg/vial) Sermorelin 86168-78-7 (2mg/vial) TB500 75591-33-4 (2mg/vial) Fragment 176-191 (2mg/vial) Gonadorelin Acetate 34973-08-5 (2mg/vial) DSIP 62568-57-4 (2mg/vial) AOD-9604 221231-10-3 (1G / foil bag) Desmopressin acetate 16789-98-3 (1G / foil bag) Eptifibatide 188627-80-7 (1G / foil bag) Hot selling list Blend 1 0.5mg cjc with dac + 0.5mg hexarelin + 1mg ipamorelin Blend 2 Ghrp-6 1mg+Ipamorelin 1mg+Cjc-1295 1mg+Mgf 500mcg Blend 3 ... Your requirement 4. More Information About Goserelin acetate: Anaphylactic reactions to ZOLADEX have been reported in the medical literature. ZOLADEX is contraindicated in patients with a known hypersensitivity to GnRH, GnRH agonist analogues, or any of the components in ZOLADEX ZOLADEX is contraindicated during pregnancy unless used for palliative treatment of advanced breast cancer. ZOLADEX can cause fetal harm when administered to a pregnant woman. If used during pregnancy, the patient should be apprised of the potential hazard to the fetus. There is an increased risk for pregnancy loss due to expected hormonal changes that occur with ZOLADEX treatment. ZOLADEX should not be given to women with undiagnosed abnormal vaginal bleeding Pregnancy must be excluded for use in benign gynecological conditions. Woman should be advised against becoming pregnant while taking ZOLADEX. Effective nonhormonal contraception must be used by all premenopausal women during ZOLADEX therapy and for 12 weeks following discontinuation of therapy Transient worsening of tumor symptoms, or the occurrence of additional signs and symptoms of breast cancer, may occasionally develop during the first few weeks of treatment. Some patients may experience a temporary increase in bone pain. Monitor patients at risk for complications of tumor flare Hyperglycemia and an increased risk of developing diabetes or worsening of glycemic control in patients with diabetes have been reported in men receiving GnRH agonists like ZOLADEX. Monitor blood glucose levels and glycosylated hemoglobin (HbA1c) periodically and manage according to current clinical practice Increased risk of developing myocardial infarction, sudden cardiac death and stroke has been reported in association with use of GnRH agonists like ZOLADEX in men. Patients receiving a GnRH agonist should be monitored for symptoms and signs suggestive of development of cardiovascular disease and be managed according to current clinical practice Hypercalcemia has been reported in some prostate and breast cancer patients with bone metastases after starting treatment with ZOLADEX. If hypercalcemia does occur, appropriate treatment measures should be initiated Hypersensitivity, antibody formation and acute anaphylactic reactions have been reported with GnRH agonist analogues ZOLADEX may cause an increase in cervical resistance. Therefore, caution is recommended when dilating the cervix for endometrial ablation ZOLADEX is supplied as a sterile, biodegradable product containing goserelin acetate equivalent to 3.6 mg of goserelin. ZOLADEX is designed for subcutaneous injection with continuous release over a 28-day period. Goserelin acetate is dispersed in a matrix of D,L-lactic and glycolic acids copolymer (13.3-14.3 mg/dose) containing less than 2.5% acetic acid and up to 12% goserelin-related substances and presented as a sterile, white to cream colored 1-mm diameter cylinder, preloaded in a special single use syringe with a 16-gauge x 36 +/- 0.5 mm siliconized needle with protective needle sleeve (SafeSystem? Syringe) in a sealed, light- and moisture-proof, aluminum foil laminate pouch containing a desiccant capsule. Studies of the D,L-lactic and glycolic acids copolymer have indicated that it is completely biodegradable and has no demonstrable antigenic potential. 5. Key words: Buy Goserelin acetate, Goserelin acetate raw powder, Goserelin acetate anabolic steroid powder, Goserelin acetate price, anabolic steroid powder Goserelin acetate, Goserelin acetate COA, Goserelin acetate manufacturer, Goserelin acetate powder, body building steroid Goserelin acetate, body building supplement Goserelin acetate, Goserelin acetate for muscle gaining, Goserelin acetate for fat burning, Goserelin acetate injection, Goserelin acetate semi-finished injection, Goserelin acetate steroid raw, Goserelin acetate raw material, Goserelin acetate fine powder, high purity Goserelin acetate powder, Goserelin acetate 99% assay, Goserelin acetate CAS, Goserelin acetate HPCL, Goserelin acetate factory 6. Seller's Information: Company: Shanghai Yijing Pharmaceutical Co., Ltd Mob: +OO86-13O26163653 7. How to place an order: Send me an email at the address above, tell me product name and quantity. |
| CAS Registry Number: | 145781-92-6 |
| Synonyms: | PYR-HIS-TRP-SER-TYR-D-SER(TBU)-LEU-ARG-PRO-AZAGLY-NH2;[(T-BU)DSER6, (AZA)GLY10]-LH-RH;[(T-BU)DSER6, (AZA)GLY10]-LUTEINIZING HORMONE-RELEASING HORMONE;GLP-HIS-TRP-SER-TYR-D-SER(TBU)-LEU-ARG-PRO-AZA-GLY-NH2;(D-SER(TBU)6,AZAGLY10)-LHRH;(D-Ser(tBu)6,Azagly10)-LHRH acetate salt;Goserelin HCl;GOSERELIN HCL[PYR-HIS-TRP-SER-TYR-D-SER(T-BU)-LEU-ARG-PRO-AZAGLY-NH2];5-oxoprolylhistidyl-N-[18,18-diamino-7-(tert-butoxymethyl)-13-({2-[(2-carbamoylhydrazinyl)carbonyl]pyrrolidin-1-yl}carbonyl)-4-(4-hydroxybenzyl)-1-(hydroxymethyl)-10-(2-methylpropyl)-2,5,8,11-tetraoxo-3,6,9,12,17-pentaazaoctadec-17-en-1-yl]tryptophanamide acetate (1:1);(2S)-N-[(2S,5S,8S,11S,14R,17S,20S)-25-amino-14-(tert-butoxymethyl)-20-({(2S)-2-[(2-carbamoylhydrazinyl)carbonyl]pyrrolidin-1-yl}carbonyl)-11-(4-hydroxybenzyl)-8-(hydroxymethyl)-1-(1H-imidazol-4-yl)-25-imino-5-(1H-indol-3-ylmethyl)-17-(2-methylpropyl)-3,6,9,12,15,18-hexaoxo-4,7,10,13,16,19,24-heptaazapentacosan-2-yl]-5-oxopyrrolidine-2-carboxamide acetate (1:1) (non-preferred name);D-Ser(tBu)6,AzaGly10)-LHRH acetate salt; |
| Molecular Formula: | C61H88N18O16 |
| Molecular Weight: | 1329.4624 |
| Molecular Structure: | 
|
| Safety Description: | S22-24/25:; |
| Company: | Shanghai Yijing Pharmaceutical Co., Ltd [ China ] |
| Contact: | Alisa |
| Tel: | +86-130-26163653 |
| Fax: | |
| Email: | alisa@pharm-china.com |
-
Disclaimer statement:The information and data included above have been realized by the enterprises and compiled by the staff, and are subject to change without notice to you. The Chemnet makes no warranties or representations whatsoever regarding the facticity, accuracy and validity of such information and data. In order to ensure your interest, we suggest you chose the products posted by our gold suppliers or VIP members.
